Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010, Article ID 842814, 4 pages
http://dx.doi.org/10.1155/2010/842814
Case Report

Pseudogout Associated Hip Pain in a Patient with HIV Infection

1North Middlesex University Hospital, Sterling Way, London N18 1QX, UK
2Watford General Hospital, Hertfordshire WD18 0HB, UK

Received 26 August 2010; Accepted 3 November 2010

Academic Editor: Ingo W. Husstedt

Copyright © 2010 Benan M. Dala-Ali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS and WHO, 2008 report on the global AIDS epidemic, UNAIDS, Geneva, Switzerland, 2008.
  2. D. Buskila, D. D. Gladman, P. Langevitz, A. A. M. Bookman, M. Fanning, and I. E. Salit, “Rheumatologic manifestations of infection with the human immunodeficiency virus (HIV),” Clinical and Experimental Rheumatology, vol. 8, no. 6, pp. 567–573, 1990. View at Google Scholar · View at Scopus
  3. A. Berman, L. R. Espinoza, J. D. Diaz et al., “Rheumatic manifestations of human immunodeficiency virus infection,” American Journal of Medicine, vol. 85, no. 1, pp. 59–64, 1988. View at Google Scholar · View at Scopus
  4. E. T. Hacbarth, C. A. Freire, and E. Atra, “Rheumatic manifestations of acquired immunodeficiency syndrome (AIDS)Manifestações reumáticas na síndrome de imunodeficiência adquirida (AIDS),” Revista da Associacao Medica Brasileira, vol. 38, no. 2, pp. 90–94, 1992. View at Google Scholar · View at Scopus
  5. F. Medina-Rodriguez, C. Guzman, L. J. Jara et al., “Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors,” Journal of Rheumatology, vol. 20, no. 11, pp. 1880–1884, 1993. View at Google Scholar · View at Scopus
  6. J. S. Lambert, M. Seidlin, R. C. Reichman et al., “2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A Phase I trial,” New England Journal of Medicine, vol. 322, no. 19, pp. 1333–1340, 1990. View at Google Scholar · View at Scopus
  7. D. Richardson, S. H. Liou, and J. O. Kahn, “Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS clinical trials group protocols 116A and 116B/117,” Journal of Acquired Immune Deficiency Syndromes, vol. 6, no. 11, pp. 1212–1223, 1993. View at Google Scholar · View at Scopus
  8. U. A. Walker, C. Hoffmann, M. Enters, J. Thoden, G. Behrens, and S. L. Mitzel, “High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters,” AIDS, vol. 20, no. 11, pp. 1556–1558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Creighton, R. Miller, S. Edwards, A. Copas, and P. French, “Is ritonavir boosting associated with gout?” International Journal of STD and AIDS, vol. 16, no. 5, pp. 362–364, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Becker and B. J. Roessler, “Hyperuricaemia and gout,” in The Metabolic and Molecular Basis of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, Eds., chapter 49, McGraw Hill, New York, NY, USA, 7th edition, 1995. View at Google Scholar
  11. I. Mineo and S. Tarui, “Myogenic hyperuricemia: what can we learn from metabolic myopathies?” Muscle and Nerve, vol. 18, no. 3, pp. S75–S81, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. B. M. Rothschild, “Calcium Pyrophosphate Deposition Disease (rheumatology),” 2008, http://www.emedicine.com/radio/topic125.htm.
  13. S. L. Day, H. A. Leake Date, A. Bannister, M. Hankins, and M. Fisher, “Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice,” Journal of Acquired Immune Deficiency Syndromes, vol. 38, no. 3, pp. 301–304, 2005. View at Google Scholar · View at Scopus
  14. M. M. Rosenvinge, K. Gedela, A. J. Copas et al., “Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency,” Journal of Acquired Immune Deficiency Syndromes, vol. 54, no. 5, pp. 496–499, 2010. View at Publisher · View at Google Scholar
  15. M. Nelson, T. Powles, A. Zeitlin et al., “Thyroid dysfunction and relationship to antiretroviral therapy in hiv-positive individuals in the HAART era,” Journal of Acquired Immune Deficiency Syndromes, vol. 50, no. 1, pp. 113–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Thomas and S. M. Doherty, “HIV infection—a risk factor for osteoporosis,” Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 3, pp. 281–291, 2003. View at Google Scholar · View at Scopus
  17. G. Ventura, G. Gasparini, M. B. Lucia et al., “Osteoarticular bacterial infections are rare in HIV-infected patients: 14 cases found among 4023 HIV-infected patients,” Acta Orthopaedica Scandinavica, vol. 68, no. 6, pp. 554–558, 1997. View at Google Scholar · View at Scopus
  18. A. Barzilai, D. Varon, U. Martinowitz, M. Heim, and S. Schulman, “Characteristics of septic arthritis in human immunodeficiency virus-infected haemophiliacs versus other risk groups,” Rheumatology, vol. 38, no. 2, pp. 139–142, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. J. S. Pascual, L. L. Balos, and A. N. Baer, “Disseminated Prototheca wickerhamii infection with arthritis and tenosynovitis,” Journal of Rheumatology, vol. 31, no. 9, pp. 1861–1865, 2004. View at Google Scholar · View at Scopus
  20. J. E. Jellis, “Bacterial infections: bone and joint tuberculosis,” Bailliere's Clinical Rheumatology, vol. 9, no. 1, pp. 151–159, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Gallant, S. Staszewski, A. L. Pozniak et al., “Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial,” Journal of the American Medical Association, vol. 292, no. 2, pp. 191–201, 2004. View at Publisher · View at Google Scholar
  22. V. Amorosa and P. Tebas, “Bone disease and HIV infection,” Clinical Infectious Diseases, vol. 42, no. 1, pp. 108–114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Thomas and S. M. Doherty, “HIV infection—a risk factor for osteoporosis,” Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 3, pp. 281–291, 2003. View at Google Scholar · View at Scopus
  24. J. Rademaker, J. S. Dobro, and G. Solomon, “Osteonecrosis and human immunodeficiency virus infection,” Journal of Rheumatology, vol. 24, no. 3, pp. 601–604, 1997. View at Google Scholar · View at Scopus
  25. K. D. Miller, H. Masur, E. C. Jones et al., “High prevalence of osteonecrosis of the femoral head in HIV-infected adults,” Annals of Internal Medicine, vol. 137, no. 1, pp. 17–24, 2002. View at Google Scholar · View at Scopus
  26. D. Meyer, G. Behrens, R. E. Schmidt, and M. Stoll, “Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors,” AIDS, vol. 13, no. 9, pp. 1147–1148, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Blangy, D. Loeuille, I. Chary-Valckenaere, B. Christian, T. May, and P. Gillet, “Osteonecrosis of the femoral head in HIV-1 patients: four additional cases,” AIDS, vol. 14, no. 14, pp. 2214–2215, 2000. View at Publisher · View at Google Scholar · View at Scopus